SCHEMBL29349748

SCHEMBL29349748

CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 2/20 0.68
▸ NTSR2 O95665 1/20 0.61
▸ NTSR1 P30989 1/20 0.61
▸ SORT1 Q99523 1/20 0.61
▸ C5AR1 P21730 1/20 0.58
▸ F2 P00734 1/20 0.57
▸ MC4R P32245 2/20 0.56
▸ MC5R P33032 2/20 0.56
▸ MC3R P41968 2/20 0.56
▸ MC1R Q01726 2/20 0.56
▸ OPRD1 P41143 2/20 0.53
▸ OPRM1 P35372 1/20 0.53
▸ OPRK1 P41145 1/20 0.53
▸ CXCR4 P61073 1/20 0.52
▸ DPP3 Q9NY33 2/20 0.52
▸ NMBR P28336 1/20 0.52
▸ GRPR P30550 1/20 0.52
▸ GNRHR P30968 1/20 0.51
▸ ABCC2 Q92887 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28271821 1.00 TACR1 (0.68) TACR1NTSR2NTSR1SORT1C5AR1
SCHEMBL28556016 0.91 MC4R (0.64) TACR1NTSR2NTSR1SORT1C5AR1
SCHEMBL28556022 0.91 MC4R (0.64) TACR1NTSR2NTSR1SORT1C5AR1
SCHEMBL29445795 0.91 MC4R (0.64) TACR1NTSR2NTSR1SORT1C5AR1
SCHEMBL31477723 0.89 TACR1 (0.74) TACR1NTSR2NTSR1SORT1F2
SCHEMBL29405987 0.89 TACR1 (0.74) TACR1NTSR2NTSR1SORT1F2
SCHEMBL30539219 0.88 MC4R (0.61) TACR1NTSR2NTSR1SORT1C5AR1
SCHEMBL29835266 0.88 MC4R (0.61) TACR1NTSR2NTSR1SORT1C5AR1
SCHEMBL29350118 0.86 TACR1 (0.78) TACR1NTSR2NTSR1SORT1C5AR1
SCHEMBL29535981 0.86 TACR1 (0.78) TACR1NTSR2NTSR1SORT1C5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 843 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122075333-A Composition containing polypeptide substances and preparation method and application thereof — 2026-05-26 — — CN claimed
WO-2026105954-A1 LIP COSMETIC MATERIAL COMPOSITION FOR IMPROVING LIP VOLUME AND AMELIORATING LIP WRINKLES 이윤진 2026-05-21 — — WO claimed
EP-4744645-A1 COSMETIC PREPARATION FOR REJUVENATING THE SKIN Prima-Derm, S.L. (ES) 2026-05-20 — — EP claimed
EP-4744644-A1 COSMETIC PREPARATION FOR REJUVENATING THE SKIN Prima-Derm, S.L. (ES) 2026-05-20 — — EP claimed
CN-122031291-A Formula of black-dispelling and whitening water-based optical needle 东莞市塘厦定妆医疗美容有限公司 2026-05-15 — — CN claimed
US-20260060912-A1 SKIN CARE PRODUCT WITH PROTEIN MATRIX Eighth Day Labs, LLC (US) 2026-03-05 — — US claimed
EP-4703370-A1 AMINO ACID-DERIVED CERAMIDE, SYNTHESIS METHOD THEREFOR AND USE THEREOF Shenzhen Dikeman Biotechnology Co., Ltd. (CN) 2026-03-04 — — EP claimed
CN-121570407-A Umbilical cord blood water-light essence composition, umbilical cord blood water-light essence and preparation method and application thereof 广州森野生物医药科技有限公司 2026-02-27 — — CN claimed
EP-4110276-B1 COMPOSITIONS COMPRISING ALKANEDIOLS SYMRISE AG (DE) 2026-01-28 — — EP claimed
US-12521335-B2 Cosmetic compositions containing vitamin C compounds and uses thereof ROC OPCO LLC (US) 2026-01-13 — — US claimed
CN-109700687-B Flexible liposome cosmetic containing active polypeptide and preparation method thereof 深圳高尚科美生物科技有限公司 2022-04-15 — — CN claimed
CN-114306126-A Water-in-oil nano emulsion and preparation method thereof 华熙生物科技股份有限公司 2022-04-12 — — CN claimed
CN-114292312-A Method for synthesizing 9 peptide-1 in full liquid phase 湖南微肽生物医药有限公司 2022-04-08 — — CN claimed
CN-113952944-B Method for purifying nonapeptide-1 浙江湃肽生物有限公司深圳分公司 2022-03-29 — — CN claimed
CN-113980098-B Nonapeptide-1 derivative and synthesis method and application thereof 浙江湃肽生物有限公司深圳分公司 2022-03-29 — — CN claimed
CN-110200875-B Anti-allergy whitening mask and preparation method thereof 中山卡丝生物科技有限公司 2022-03-18 — — CN claimed
CN-114191319-A Semitransparent emulsion composition for improving skin color and preparation method thereof 江苏芙肽生物科技有限公司 2022-03-18 — — CN claimed
CN-114028258-A Whitening essence 朱学军 2022-02-11 — — CN claimed
CN-113980098-A Nonapeptide-1 derivative and synthesis method and application thereof 浙江湃肽生物有限公司深圳分公司 2022-01-28 — — CN claimed
CN-113952944-A Method for purifying nonapeptide-1 浙江湃肽生物有限公司深圳分公司 2022-01-21 — — CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060912-A1 SKIN CARE PRODUCT WITH PROTEIN MATRIX CUTA, HGFAC, BHMT TACR1 3191/4885NTSR2 2565/4885NTSR1 2401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback